StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $1.18 on Friday. Retractable Technologies has a fifty-two week low of $0.95 and a fifty-two week high of $1.90. The company has a market capitalization of $35.33 million, a PE ratio of -3.19 and a beta of 2.12. The stock has a fifty day moving average of $1.23 and a two-hundred day moving average of $1.17. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.97 and a current ratio of 8.40.

Hedge Funds Weigh In On Retractable Technologies

A number of large investors have recently bought and sold shares of the stock. Bridgeway Capital Management LLC raised its position in shares of Retractable Technologies by 20.1% in the 4th quarter. Bridgeway Capital Management LLC now owns 149,534 shares of the company’s stock worth $166,000 after buying an additional 25,000 shares during the period. WealthTrust Axiom LLC raised its holdings in shares of Retractable Technologies by 27.8% in the 3rd quarter. WealthTrust Axiom LLC now owns 126,533 shares of the company’s stock worth $151,000 after purchasing an additional 27,500 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Retractable Technologies by 21.1% in the 2nd quarter. Renaissance Technologies LLC now owns 195,171 shares of the company’s stock valued at $224,000 after purchasing an additional 33,947 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its holdings in shares of Retractable Technologies by 314.2% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 58,400 shares of the company’s stock worth $96,000 after purchasing an additional 44,300 shares during the period. Finally, Jane Street Group LLC acquired a new stake in Retractable Technologies during the 4th quarter worth approximately $27,000. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.